IRD Next Earnings Date Notes

— Opus Genetics (ticker symbol IRD) is a clinical-stage biotechnology company focused on developing gene therapies targeting inherited retinal diseases, with an emphasis on conditions that cause sight loss such as Leber congenital amaurosis (LCA) & other monogenic retinal disorders. Leveraging cutting-edge adeno-associated virus (AAV) technology, Opus aims to address significant unmet medical needs in ophthalmology by advancing novel therapies from the lab to clinical trials. For investors tracking IRD, the most relevant metrics to watch include progress in clinical trial enrollment & results, FDA feedback or regulatory milestones, cash runway & R&D expenditure, as well as partnership or licensing deals. Pipeline advancement—measured through data readouts, new indications, & expansion into larger patient bases—will also significantly impact long-term value. During the upcoming earnings call, pay close attention to management commentary on trial timelines, any updates on regulatory interactions, and insights on commercial strategy for eventual product launches. These factors will help gauge Opus Genetics’ ability to reach pivotal value-creation milestones in the competitive gene therapy landscape. The next projected earnings date for IRD is 8/12/2026 after close (stay tuned for a confirmed earnings date once announced).

IRD Next Earnings Date FAQ

On this page we presented the IRD Next Earnings Date information for Opus Genetics along with recent past earnings dates. For Q1 of 2026, IRD reported earnings of -0.750/share, with the earnings report taking place on 5/12/2026. For Q4 of 2025, IRD reported earnings of /share, with the earnings report taking place on 3/30/2026. For Q4 of 2025, IRD reported earnings of -0.210/share, with the earnings report taking place on 3/10/2026. For Q3 of 2025, IRD reported earnings of -0.250/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, IRD reported earnings of -0.120/share, with the earnings report taking place on 8/13/2025. Based on these past earnings dates, the projected next earnings date for IRD is 8/12/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Opus Genetics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Opus Genetics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Opus Genetics next earnings dates as well as any other stock out there in our coverage universe, to see when the next IRD earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up IRD's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the IRD next earnings date.